Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis — Stella

Home/Dialysis; Complications/

View on ClinicalTrials.gov

Recruiting

Back to Dialysis; Complications trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Chinese PLA General Hospital, Beijing, Beijing Municipality

Key details

Phase

Post-approval study

Sponsor

Chinese PLA General Hospital

Collaborators

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Enrollment target

~240 participants

Started

August 2025

Primary completion

December 2027

Age range

18 Years – 80 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.